Immunocytochemical study of BCR and BCR-ABL localization in K562 cells

Experimental Oncology

Volumn 32, Issue 2, 2010, Pages 81-83

  Telegeev, G D ^a   Dubrovska, A N ^a   Nadgorna, V A ^b   Dybkov, M V ^a   Zavelevich, M P ^b   Maliuta, S S ^a   Gluzman, D F ^b  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

ALL; Bcr Abl; CML; K562 cells; Philadelphia chromosome; Polyclonal antibodies

Indexed keywords

BCR ABL PROTEIN; BREAST CANCER RESISTANCE PROTEIN; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ANTIBODY PRODUCTION; ANTIGEN RECOGNITION; ARTICLE; CELL STRAIN K 562; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PHILADELPHIA 1 CHROMOSOME; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; CYTOPLASM; FUSION PROTEINS, BCR-ABL; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCR; RABBITS; RECOMBINANT PROTEINS;

EID: 77954600931     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rowley JD. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290-3.
2. Goldman JM, Melo JV. Chronic myeloid leukemia - advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451-64.
3. Dubrovska AN, Telegeev GD, Dybkov MV, et al. Mutational analysis and bacterial expression of chimerical oncoprotein Bcr/Abl. Biopolymers and Cell 2002; 18: 96-101 (In Russian).
4. Miroshnychenko DO, Dubrovska AN, Telegeev GD, et al. Assessment of specificity of protein-lipid and protein-protein interactions of PH domain of Bcr protein associated with chronic myelogenous leukemia. Biopolymers and Cell 2007; 23: 405-9.
5. McWhirter JR, Wang JYJ. Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol 1991; 11: 1553-65.
6. Calabretta B, Perrotti D. The biology of CML blast crisis. Blood 2004; 103: 4010-22.
7. Dixon AS, Kakar M, Schneider KM, et al. Controlling subcellular localization to alter function: Sending oncogenic Bcr-Abl to the nucleus causes apoptosis. J Control Release 2009; 140: 245-9.
8. McWhirter JR, Wang JY. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein. Oncogene 1997; 15: 1625-34.
9. Skourides PA, Perera SA, Ren R. Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins. Oncogene 1999; 18: 1165-76. (Pubitemid 29085989)
10. Miroshnychenko D, Dubrovska A, Maliuta S, et al. Novel role of pleckstrin homology domain of the Bcr-Abl protein: analysis of protein-protein and protein-lipid interactions. Exp Cell Res 2010; 316: 530-42.
11. Radziwill G, Erdmann RA, Margelisch U, et al. The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain. Mol Cell Biol 2003; 23: 4663-72. (Pubitemid 36734754)
12. Malmberg EK, Andersson CX, Gentzsch M, et al. Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold protein PDZK1 and vesicle coat protein Mint3. J Cell Sci 2004; 117: 5535-41. (Pubitemid 40012200)
13. Cho YJ, Cunnick JM, Yi SJ, et al. Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages. Mol Cell Biol 2007; 27: 899-911.